A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1/2a study.
The purpose of Phase 1 was to evaluate the safety and tolerability of DRM01B Topical Gel in 6
healthy volunteers.
The purpose of Phase 2a was to assess the safety, tolerability and preliminary efficacy of
DRM01B Topical Gel compared to vehicle in subjects with acne vulgaris on the face.